Quantcast

Posts related to ‘Carl Icahn and Forest Labs’

Pills

Forest Labs Sputters on Patent Expiration

Forest Laboratories Inc. (NYSE: FRX) reported third-quarter fiscal 2013 results before markets opened this morning. The drug maker and marketer reported an adjusted diluted earnings per share (EPS) loss of ...
Read Full Story »

Media Digest (7/3/2012) Reuters, WSJ, FT, Bloomberg

Bob Diamond, CEO of Barclays (NYSE: BCS), quits. (Reuters) Microsoft (NASDAQ: MSFT) takes a $6.2 billion write-off, primarily due to its buyout of aQuantive. (Reuters) The U.S. probe begins on ...
Read Full Story »